You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 106 No. 11, November 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (65)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Collagen-Shield Delivery of Gentamicin and Vancomycin

Richard B. Phinney, MD; Steven D. Schwartz, MD; David A. Lee, MD; Bartly J. Mondino, MD

Arch Ophthalmol. 1988;106(11):1599-1604.


Abstract

• The ability of collagen-shield therapeutic contact lenses to release gentamicin sulfate and vancomycin hydrochloride individually and in combination was investigated using a fluorescent polarization immunoassay. In vitro studies showed that presoaked collagen shields released the majority of gentamicin within the first 30 minutes of elution, while vancomycin was released gradually over six hours of elution. Three experiments in rabbits compared the gentamicin and vancomycin levels produced at five time points in tears, cornea, and aqueous humor by collagen shields soaked in antibiotics vs frequent-drop therapy. The collagen shields soaked in gentamicin, vancomycin, or a combination of the two produced tear, cornea, and aqueous humor levels that were generally higher or at least comparable with those achieved by frequent-drop therapy.



Author Affiliations

From the Jules Stein Eye Institute, Department of Ophthalmology, UCLA School of Medicine.


Footnotes

Accepted for publication June 21, 1988.

Reprint requests to the Jules Stein Eye Institute, UCLA Medical Center, 10833 LeConte Ave, Los Angeles, CA 90024-1771 (Dr Lee).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin
Cahane et al.
Br J Ophthalmol 2004;88:22-24.
ABSTRACT | FULL TEXT  

Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids
Alster et al.
Br J Ophthalmol 2000;84:300-302.
ABSTRACT | FULL TEXT  

Aminoglycoside Macular Infarction in Association With Gentamicin-Soaked Collagen Corneal Shield
Kanter and Brucker
Arch Ophthalmol 1995;113:1359-1360.
ABSTRACT  

Corneal Toxicity With an Antibiotic/Steroid--Soaked Collagen Shield
Pflugfelder and Murchison
Arch Ophthalmol 1992;110:20-20.
ABSTRACT  

Characterization of Infectious Crystalline Keratitis Caused by a Human Isolate of Streptococcus mitis
McDonnell et al.
Arch Ophthalmol 1991;109:1147-1151.
ABSTRACT  

Collagen Shield Heparin Delivery for Prevention of Postoperative Fibrin
Murray et al.
Arch Ophthalmol 1990;108:104-106.
ABSTRACT  

Collagen Shield Enhancement of Topical Dexamethasone Penetration
Hwang et al.
Arch Ophthalmol 1989;107:1375-1380.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.